Lavipharm SA announces, according to article 4.1.3.1, par. ib of the ASE Regulation, that the regular Tax Audit of the company for fiscal year 2006 has been completed, by which the Company assessed additional taxes and fees amounting to Euro 1.667.993,50 (taxes Euro 1.285.187,41, increments Euro 361.707,49 and fines Euro 21.098,60). An amount of Euro 847.993,50 will burden the current year, since the company had taken provisions for the remaining amount of Euro 820.000,00.